Canada can be a leader in delivering widespread, well-regulated psychedelic-assisted therapy for people with depression, anxiety, post-traumatic stress disorder and substance abuse, by investing in research, educating health care professionals and providing the necessary clinical infrastructure, Dr. Ross Marshall, chief scientific officer at The Newly Institute based in Calgary, says in an op-ed.
Organization: Multidisciplinary Association for Psychedelic Studies
$5-million donation boosts psychedelic science in Canada
Psychedelics research in Canada got a major boost this week with a $5-million donation to Toronto’s University Health Network to establish the Nikean Psychedelic Psychotherapy Research Centre.
The Short Report – Sept. 29, 2021: Alan Bernstein forgoes third term as CIFAR’s CEO & President, UHN receives funding gift for psychedelic psychotherapy, and more
Dr. Alan Bernstein to forgo third term leading CIFAR, Nikean Foundation gift marks largest contribution towards psychedelic science and research in Canada, Bruce Power takes the next step towards new isotope production, and more.